We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

84 hedge funds and large institutions have $87.5M invested in VanEck Biotech ETF in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

335% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $436K

29% more capital invested

Capital invested by funds: $67.8M → $87.5M (+$19.6M)

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

3.9% more ownership

Funds ownership: 16.34% → 20.24% (+3.9%)

1% more funds holding

Funds holding: 83 → 84 (+1)

46% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 24

Holders
84
Holders Change
+1
Holders Change %
+1.2%
% of All Funds
1.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
13
Reduced
24
Closed
8
Calls
$1.9M
Puts
$436K
Net Calls
+$1.46M
Net Calls Change
+$1.59M

Top Buyers

Rank Fund Capital Flow
1
CWM
Cornerstone Wealth Management
Missouri
+$8.99M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.5M
3
VF
Virtu Financial
New York
+$3.59M
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.36M
5
Jane Street
Jane Street
New York
+$1.18M

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$830K
2
ClearBridge Investments
ClearBridge Investments
New York
-$540K
3
OAM
Occidental Asset Management
California
-$432K
4
TRCT
Tower Research Capital (TRC)
New York
-$422K
5
MCM
Murphy Capital Management
New Jersey
-$412K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
76
JP Morgan Chase
New York
$13K – – –
ATC
77
Adirondack Trust Company
New York
$10K – – –
BWM
78
Baystate Wealth Management
Massachusetts
$6K – – –
GRP
79
Global Retirement Partners
California
$6K – – –
SWP
80
Stratos Wealth Partners
Ohio
$6K +$5.85K +45 New
QAM
81
QCI Asset Management
New York
$3K – – –
SWM
82
SeaCrest Wealth Management
New York
$3K – – –
AIP
83
Ameritas Investment Partners
Nebraska
$2K – – –
CAPTRUST Financial Advisors
84
CAPTRUST Financial Advisors
North Carolina
$2K +$2.08K +16 New
OAM
85
Occidental Asset Management
California
– -$432K -3,601 Closed
Simplex Trading
86
Simplex Trading
Illinois
– -$149K -1,245 Closed
SEI Investments
87
SEI Investments
Pennsylvania
– -$18K -150 Closed
CF
88
Centaurus Financial
California
– -$15K -126 Closed
BC
89
Barnett & Company
Tennessee
– -$12K -100 Closed
CIBC Private Wealth Group
90
CIBC Private Wealth Group
Georgia
– -$10K -80 Closed
JCM
91
Jacobi Capital Management
Pennsylvania
– -$7K -60 Closed
PGWM
92
Parisi Gray Wealth Management
New Jersey
– -$2K -18 Closed
1 2 3
4

BBH Hedge Fund Activity: Q3 2018 in Review

84 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2018, worth a combined $87.5M — up 29% from $67.8M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BBH positions and 8 closed out — a net gain of 2 holders — while 13 added to existing stakes and 24 trimmed.

The largest buyer was Cornerstone Wealth Management, opening a new position worth an estimated $8.99M. The largest seller was UBS Group, cutting an estimated $830K.

  • 84 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2018, up from 83 in Q2 2018.
  • Funds reported $87.5M of VanEck Biotech ETF stock for Q3 2018, up 29% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q3 2018 and 8 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2018 was Cornerstone Wealth Management, an estimated $8.99M added.
  • The largest VanEck Biotech ETF seller in Q3 2018 was UBS Group, an estimated $830K sold.

Based on aggregated 13F filings for Q3 2018.